Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.86.3ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
BA.2.86.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.2.86.3NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
BA.2.86.3NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BA.2.86.3ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
GN.4ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
GN.4ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
GN.4ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
GN.4ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
GN.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GN.4NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
GN.4NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
GN.4ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-2648.21Japan
XBB.8.2ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
XBB.8.2ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
XBB.8.2ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
XBB.8.2ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
XBB.8.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.8.2NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
XBB.8.2NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
XBB.8.2ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-2648.21Japan
HB.1ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
HB.1ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
HB.1ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
HB.1ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
HB.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HB.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
HB.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
HB.1ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
EG.10.1ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
EG.10.1ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
EG.10.1ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
EG.10.1ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
EG.10.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
EG.10.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
EG.10.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
EG.10.1ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
XBB.1.5.89ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-2539.84China
XBB.1.5.89ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
XBB.1.5.89ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-301.668South Korea
XBB.1.5.89ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
XBB.1.5.89SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.89NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
XBB.1.5.89NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
XBB.1.5.89ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
HR.1ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
HR.1ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
HR.1ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
HR.1ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
HR.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used